LSA
AXSM icon

Leonteq Securities AG’s Axsome Therapeutics AXSM Stock Holding History

Leonteq Securities AG’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-400
Closed -$31.8K – 1205
2023
Q4 		$31.8K Hold
400
– – ﹤0.01% 861
2023
Q3 		$28K Buy
+400
New +$29.9K ﹤0.01% 899
2023
Q1 		– Sell
-2,000
Closed -$154K – 1216
2022
Q4 		$154K Buy
+2,000
New +$120K 0.01% 594

Other funds holding AXSM

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Leonteq Securities AG's AXSM Position: Q2 2026 in Review

Leonteq Securities AG reduced its Axsome Therapeutics (AXSM) stake by 1.1% in Q2 2026, selling an estimated $6.07K and leaving 2,616 shares worth $640K. The position accounts for 0.02% of the portfolio, ranked #348.

Leonteq Securities AG first reported a position in AXSM in Q1 2022 and has held it in 18 quarters since. 102 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Leonteq Securities AG held 2,616 shares of Axsome Therapeutics worth $640K as of Q2 2026.
  • Leonteq Securities AG sold 28 Axsome Therapeutics shares in Q2 2026, an estimated $6.07K.
  • Axsome Therapeutics made up 0.02% of Leonteq Securities AG's portfolio in Q2 2026, its #348 holding.
  • Leonteq Securities AG first reported a position in Axsome Therapeutics in Q1 2022 and has held it in 18 quarters since.
  • 102 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.